376 related articles for article (PubMed ID: 35744923)
1. Aphrodisiac Performance of Bioactive Compounds from
Palanichamy C; Pavadai P; Panneerselvam T; Arunachalam S; Babkiewicz E; Ram Kumar Pandian S; Shanmugampillai Jeyarajaguru K; Nayak Ammunje D; Kannan S; Chandrasekaran J; Sundar K; Maszczyk P; Kunjiappan S
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744923
[TBL] [Abstract][Full Text] [Related]
2.
Palanichamy C; Nayak Ammunje D; Pavadai P; Ram Kumar Pandian S; Theivendren P; Kabilan SJ; Babkiewicz E; Maszczyk P; Kunjiappan S
J Biomol Struct Dyn; 2023 Dec; ():1-20. PubMed ID: 38088340
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study.
Huang YY; Li Z; Cai YH; Feng LJ; Wu Y; Li X; Luo HB
J Chem Inf Model; 2013 Nov; 53(11):3044-53. PubMed ID: 24180640
[TBL] [Abstract][Full Text] [Related]
4. Natural phosphodiesterase 5 (PDE5) inhibitors: a computational approach.
Ongaro A; Zagotto G; Memo M; Gianoncelli A; Ribaudo G
Nat Prod Res; 2021 May; 35(10):1648-1653. PubMed ID: 31140295
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Inhibitors of PDE5 based on Structure-based Virtual Screening Approaches.
Xu L; Sun L; Su P; Ma T; Yu Y; Liu H; Huang X
Curr Comput Aided Drug Des; 2023; 19(3):234-242. PubMed ID: 36503473
[TBL] [Abstract][Full Text] [Related]
6. In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors.
Kayık G; Tüzün NŞ; Durdagi S
J Biomol Struct Dyn; 2017 Oct; 35(13):2830-2852. PubMed ID: 27581752
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
Corbin JD; Francis SH; Webb DJ
Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
[TBL] [Abstract][Full Text] [Related]
8. The traditional use of native Brazilian plants for male sexual dysfunction: Evidence from ethnomedicinal applications, animal models, and possible mechanisms of action.
Teixeira TM; Boeff DD; de Oliveira Carvalho L; Ritter MR; Konrath EL
J Ethnopharmacol; 2024 Jan; 318(Pt A):116876. PubMed ID: 37437795
[TBL] [Abstract][Full Text] [Related]
9. Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development.
Kayık G; Tüzün NŞ; Durdagi S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):311-330. PubMed ID: 28150511
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoinformatics-based investigation of bioactive compounds of Rasam (South Indian recipe) against human cancer.
Kalimuthu AK; Panneerselvam T; Pavadai P; Pandian SRK; Sundar K; Murugesan S; Ammunje DN; Kumar S; Arunachalam S; Kunjiappan S
Sci Rep; 2021 Nov; 11(1):21488. PubMed ID: 34728718
[TBL] [Abstract][Full Text] [Related]
11. Identifying Phosphodiesterase-5 Inhibitors with Drug Repurposing Approach: Implications in Vasodysfunctional Disorders.
Khan MS; Mohammad HA; Shahwan M; Yadav DK; Anwar S; Shamsi A
ChemistryOpen; 2024 May; 13(5):e202300196. PubMed ID: 38060834
[TBL] [Abstract][Full Text] [Related]
12. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
[TBL] [Abstract][Full Text] [Related]
13. Medicinal plants as a potential source of Phosphodiesterase-5 inhibitors: A review.
Anand Ganapathy A; Hari Priya VM; Kumaran A
J Ethnopharmacol; 2021 Mar; 267():113536. PubMed ID: 33137431
[TBL] [Abstract][Full Text] [Related]
14.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
15. Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors.
Temkitthawon P; Hinds TR; Beavo JA; Viyoch J; Suwanborirux K; Pongamornkul W; Sawasdee P; Ingkaninan K
J Ethnopharmacol; 2011 Oct; 137(3):1437-41. PubMed ID: 21884777
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
17. Exploring the association between erectile rigidity and treatment adherence with sildenafil.
Mazzola CR; Deveci S; Teloken P; Mulhall JP
J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943
[TBL] [Abstract][Full Text] [Related]
18. Exploring the structure determinants of pyrazinone derivatives as PDE5 3HC8 inhibitors: an in silico analysis.
Li Y; Wu W; Ren H; Wang J; Zhang S; Li G; Yang L
J Mol Graph Model; 2012 Sep; 38():112-22. PubMed ID: 23085160
[TBL] [Abstract][Full Text] [Related]
19.
Mandal AK; Pandey A; Sah RK; Baral A; Sah P
Evid Based Complement Alternat Med; 2022; 2022():6790314. PubMed ID: 36248409
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5.
Sawant SD; Lakshma Reddy G; Dar MI; Srinivas M; Gupta G; Sahu PK; Mahajan P; Nargotra A; Singh S; Sharma SC; Tikoo M; Singh G; Vishwakarma RA; Syed SH
Bioorg Med Chem; 2015 May; 23(9):2121-8. PubMed ID: 25801159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
